Sunshine Biopharma Inc. · Brief

Next report

8 days

Nov 12 · after closeest.Q3 FY26

Expected move

No implied move.

No reported quarters.

Nov 12 report · est.

—

SBFM report session

No linked exposure.

Oct 23haltTrading halt: 19:50 ET, resumed 09:00 ET.Source

Oct 98-KMaterial agreement: placement agent agreement with Aegis Capital Corp.Source

Oct 7haltTrading halt: 11:59 ET, resumed 12:04 ET.Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.